FDA Approves Rilpivirine, Cabotegravir as the First Long-Acting Regimen for HIV Treatment
January 23rd 2021The FDA has approved cabenuva, which consists of rilpivirine and cabotegravir, for treating HIV-1 infection in adults. This therapy is the first once-monthly, long-acting injectable to be approved for the treatment of HIV.
Read More
Severe Menopause Symptoms Linked With Premature Ovarian Insufficiency
January 22nd 2021Health care providers should be more cognizant of psychological complications and sexual dysfunction risks in women with premature ovarian insufficiency and should work with patients to identify options for relief.
Read More
Triggering a Tumor Antiviral Immune Response in Patients With Triple-Negative Breast Cancer
January 22nd 2021During a study investigating therapeutics that target how RNA splicing activates antiviral immune pathways in triple-negative breast cancers, researchers observed that endogenous RNA in tumor cells that had been mis-spliced is able to mimic an RNA virus.
Read More
Survey Finds Vast Majority of Pharmacists Plan to or Have Been Vaccinated Against COVID-19
January 22nd 2021In successive surveys over the past several months, an increasing number of pharmacists said they plan to be immunized, plan to manage the logistics of handling the vaccine, and will administer it to patients.
Read More
Study: Fried Food Intake Linked to Heightened Serious Heart Disease, Stroke Risk
January 21st 2021The study authors noted that although the Western diet does not promote good cardiovascular health, it is not clear exactly what contribution fried food might make to the risks of serious heart disease and stroke.
Read More
Study: Sharp Decline in Cancer Screenings, Diagnoses During the First COVID-19 Surge
January 21st 2021The study findings emphasize the need for people who missed or postponed a cancer screening test early in the pandemic to contact their health care provider to discuss the potential need to reschedule it, according to the study authors.
Read More
FDA Grants Priority Review to Treatment for Resected Esophageal or Gastroesophageal Junction Cancer
January 21st 2021FDA grant priority review to a supplemental biologics license application for nivolumab (Opdivo) for use as an adjuvant treatment for patients with resected esophageal or gastroesophageal junction cancer.
Read More
Study: Temperature Scanners of Limited Value in Detecting COVID-19
January 20th 2021A new study published in Experimental Physiology suggests that taking temperature readings of a person’s fingertip and eye would give a significantly better and more reliable reading and help identify those with fever compared to a full body scan.
Read More